Filing Details
- Accession Number:
- 0001019687-10-003461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-24 16:36:23
- Reporting Period:
- 2010-09-23
- Filing Date:
- 2010-09-24
- Accepted Time:
- 2010-09-24 16:36:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 704562 | Peregrine Pharmaceuticals Inc | PPHM | In Vitro & In Vivo Diagnostic Substances (2835) | 953698422 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244106 | W Steven King | C/O Peregrine Pharmaceuticals, Inc. 14282 Franklin Avenue Tustin, CA 92780 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2010-09-23 | 5,000 | $1.33 | 93,311 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | $0.00 | 0 | 411,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 0 | 411,000 | Direct |
Footnotes
- Includes performance-based restricted shares issued pursuant to a Stock Issuance Agreement dated February 1, 2010.
- Not applicable.
Billionaire Hedge Funds
